The sialidase inhibitor, DANA, reduces Porphyromonas gingivalis pathogenicity and exerts anti‐inflammatory effects: An in vitro and in vivo experiment-Reference-Cited by-同舟云学术

The sialidase inhibitor, DANA, reduces Porphyromonas gingivalis pathogenicity and exerts anti‐inflammatory effects: An in vitro and in vivo experiment

Published:2020-07-21 Issue:2 Volume:92 Page:286-297
ISSN:0022-3492
Container-title:Journal of Periodontology
language:en
Short-container-title:J Periodontol

Author:

Yu Shiwen¹,Fan Xiaomiao¹,Zheng Shaowen¹²,Lin Li¹,Liu Jingbo¹²,Pan Yaping¹,Li Chen¹^ORCID

Affiliation:

1. School and Hospital of Stomatology China Medical University Shenyang Liaoning China

2. Liaoning Provincial Key Laboratory of Oral Disease Shenyang Liaoning China

Publisher

Wiley

Subject

Periodontics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/JPER.19-0688

Reference50 articles.

1. Periodontal diseases

2. Lewis and AB0 blood group-phenotypes in periodontitis, cardiovascular disease, obesity and stroke

3. Treating periodontal disease for preventing adverse birth outcomes in pregnant women;Iheozor‐Ejiofor Z;Cochrane Database Syst Rev,2017

4. Characterization of macrophage polarization in periodontal disease

5. Inflammatory and immune pathways in the pathogenesis of periodontal disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sialic acid metabolism of oral bacteria and its potential role in colorectal cancer and Alzheimer's disease;Carbohydrate Research;2024-07

2. Opportunistic pathogen Porphyromonas gingivalis targets the LC3B-ceramide complex and mediates lethal mitophagy resistance in oral tumors;ISCIENCE;2024

3. Opportunistic pathogen Porphyromonas gingivalis targets the LC3B-ceramide complex and mediates lethal mitophagy resistance in oral tumors;iScience;2024-06

4. Functional and structural analyses reveal that a dual domain sialidase protects bacteria from complement killing through desialylation of complement factors;PLOS Pathogens;2023-09-25

5. Small molecule inhibitors of mammalian glycosylation;Matrix Biology Plus;2022-12